pubmed-article:11456498 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11456498 | lifeskim:mentions | umls-concept:C0031676 | lld:lifeskim |
pubmed-article:11456498 | lifeskim:mentions | umls-concept:C1514562 | lld:lifeskim |
pubmed-article:11456498 | lifeskim:mentions | umls-concept:C1883221 | lld:lifeskim |
pubmed-article:11456498 | lifeskim:mentions | umls-concept:C1167622 | lld:lifeskim |
pubmed-article:11456498 | lifeskim:mentions | umls-concept:C1546857 | lld:lifeskim |
pubmed-article:11456498 | lifeskim:mentions | umls-concept:C1883204 | lld:lifeskim |
pubmed-article:11456498 | lifeskim:mentions | umls-concept:C0205266 | lld:lifeskim |
pubmed-article:11456498 | lifeskim:mentions | umls-concept:C1880389 | lld:lifeskim |
pubmed-article:11456498 | lifeskim:mentions | umls-concept:C0070797 | lld:lifeskim |
pubmed-article:11456498 | pubmed:issue | 29 | lld:pubmed |
pubmed-article:11456498 | pubmed:dateCreated | 2001-7-17 | lld:pubmed |
pubmed-article:11456498 | pubmed:abstractText | FYVE domains are small zinc-finger-like domains found in many proteins that are involved in regulating membrane traffic and have been shown to bind specifically to phosphatidylinositol 3-phosphate (PtdIns-3-P). FYVE domains are thought to recruit PtdIns-3-P effectors to endosomal locations in vivo, where these effectors participate in controlling endosomal maturation and vacuolar protein sorting. We have compared the characteristics of PtdIns-3-P binding by the FYVE domain from Hrs-1 (the hepatocyte growth factor-regulated tyrosine kinase substrate) with those of specific phosphoinositide binding by Pleckstrin homology (PH) domains. Like certain PH domains (such as that from phospholipase C-delta(1)), the Hrs-1 FYVE domain specifically recognizes a single phosphoinositide. However, while phosphoinositide binding by highly specific PH domains is driven almost exclusively by interactions with the lipid headgroup, this is not true for the Hrs-1 FYVE domain. The phospholipase C-delta(1) PH domain shows a 10-fold preference for binding isolated headgroup over its preferred lipid (phosphatidylinositol 4,5-bisphosphate) in a membrane, while the Hrs-1 FYVE domain greatly prefers (more than 50-fold) intact lipid in a bilayer over the isolated headgroup (inositol 1,3-bisphosphate). By contrast with reports for certain PH domains, we find that this preference for membrane binding over interaction with soluble lipid headgroups does not require FYVE domain oligomerization. | lld:pubmed |
pubmed-article:11456498 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:language | eng | lld:pubmed |
pubmed-article:11456498 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11456498 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11456498 | pubmed:month | Jul | lld:pubmed |
pubmed-article:11456498 | pubmed:issn | 0006-2960 | lld:pubmed |
pubmed-article:11456498 | pubmed:author | pubmed-author:KleinD EDE | lld:pubmed |
pubmed-article:11456498 | pubmed:author | pubmed-author:LemmonM AMA | lld:pubmed |
pubmed-article:11456498 | pubmed:author | pubmed-author:SankaranV GVG | lld:pubmed |
pubmed-article:11456498 | pubmed:author | pubmed-author:SachdevaM MMM | lld:pubmed |
pubmed-article:11456498 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11456498 | pubmed:day | 24 | lld:pubmed |
pubmed-article:11456498 | pubmed:volume | 40 | lld:pubmed |
pubmed-article:11456498 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11456498 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11456498 | pubmed:pagination | 8581-7 | lld:pubmed |
pubmed-article:11456498 | pubmed:dateRevised | 2009-7-17 | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:meshHeading | pubmed-meshheading:11456498... | lld:pubmed |
pubmed-article:11456498 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11456498 | pubmed:articleTitle | High-affinity binding of a FYVE domain to phosphatidylinositol 3-phosphate requires intact phospholipid but not FYVE domain oligomerization. | lld:pubmed |
pubmed-article:11456498 | pubmed:affiliation | Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. | lld:pubmed |
pubmed-article:11456498 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11456498 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11456498 | lld:pubmed |